29.07.2015
- A new experimental Alzheimer’s drug, solanezumab, developed by Eli Lilly has raised hopes for a breakthrough in the treatment of the disease. The progress was reported at the...
13.07.2015
- In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...
05.09.2014
- Catalent Pharma Solutions is installing new automated prefilled syringe clinical packaging lines at its Clinical Supply Center of Excellence in Philadelphia, Pennsylvania, USA, to...
02.09.2014
- The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
02.06.2014
- Danish drugmaker Novo Nordisk, the world's biggest insulin producer, has decided to launch its diabetes drug Tresiba in Germany after seeing signs of a more favorable pricing...
29.05.2014
- US drugmaker Eli Lilly has struck a licensing deal with Sanofi that would allow its French rival to pursue regulatory approval for a non-prescription version of Lilly's erectile...
